Patient-specific Fluorescence Aberration Profiles during Longitudinal Clinical Trials

Home > Science Hub > Patient-specific Fluorescence Aberration Profiles during Longitudinal Clinical Trials
Back to the list

June 8, 2018

Dominic Gagnon, Damien Montamat-Sicotte, Josianne Chagnon-Choquet, Vicky Sgouroudis, Philippe Pouliot & Virginia Litwin

Patient-specific Fluorescence Aberration Profiles during Longitudinal Clinical Trials, AAPS 2018

Patient-specific Fluorescence Aberration Profiles during Longitudinal Clinical Trials

Download poster

You might also be interested by

Brochures

Cell Therapy

December 15, 2023

Histopathology

More info

Infographics

Next-Generation Flow Cytometry Analysis with CellEngine™

January 31, 2023

Immune Monitoring

More info

CellTalk Blog

Discover Metadata-Driven Cytometry Analysis With CellEngine™

January 31, 2023

Immune Monitoring

More info

CellTalk Blog

Easy, Customized Autogating With CellEngine™

December 14, 2022

Immune Monitoring

More info